Clinical Trial Update: Therapeutic Effects of Silymarin in Patients With B-thalassemia Major [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports on the investigation of silymarin for beta-thalassemia major with iron overload in Phase 2 and Phase 3 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major
• Iron Overload

Drugs mentioned

• Silymarin (silymarin)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Beta-thalassemia Major, Iron Overload | Phase 2, Phase 3 | Status: UNKNOWN